MSA Safety Inc MSA
Last close
188.69
2026-09-04
Market cap
$7.28B
2026-06-30 share count
52-week range
151.10 - 208.92
Valuation FY2025 figures against the last close
P/S3.9x
P/E26.6x
P/FCF24.6x
EV/EBITDA17.4x
Dividend yield1.1%
Diluted EPS7.09
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.87B | $1.81B | $1.79B | $1.53B | $1.40B | $1.35B | $1.40B | $1.36B | $1.20B | $1.15B |
| Cost of revenue | $1.00B | $947.7M | $935.5M | $854.1M | $784.8M | $752.7M | $763.4M | $746.2M | $657.9M | $627.3M |
| Gross profit | $871.1M | $860.4M | $852.1M | $673.8M | $615.3M | $595.5M | $638.6M | $611.9M | $538.9M | $522.2M |
| R&D | $65.3M | $66.5M | $68.0M | $57.0M | $57.8M | $58.3M | $57.8M | $52.7M | $50.1M | $46.8M |
| SG&A | $414.3M | $394.7M | $396.6M | $338.9M | $332.9M | $290.3M | $330.5M | $324.8M | $300.1M | $308.2M |
| Operating income | $371.8M | $389.2M | $231.3M | $239.1M | $22.8M | $171.9M | $188.2M | $173.5M | $39.6M | $160.7M |
| Interest expense | $31.8M | $36.9M | $46.7M | $21.7M | $10.8M | $9.4M | $13.6M | $18.9M | $15.4M | $16.4M |
| Pre-tax income | $366.4M | $375.0M | $206.7M | $238.5M | $23.6M | $168.1M | $185.8M | $162.3M | $29.8M | $151.9M |
| Income tax | $87.5M | $90.0M | $148.1M | $58.9M | $1.8M | $43.0M | $46.5M | $37.2M | $2.8M | $57.8M |
| Net income | $278.9M | $285.0M | $58.6M | $179.6M | $21.3M | $124.1M | $138.0M | $124.2M | $26.0M | $91.9M |
| EPS, basic | 7.11 | 7.24 | 1.49 | 4.58 | 0.54 | 3.19 | 3.56 | 3.23 | 0.68 | 2.45 |
| EPS, diluted | 7.09 | 7.21 | 1.48 | 4.56 | 0.54 | 3.15 | 3.52 | 3.18 | 0.67 | 2.42 |
| Shares, diluted (wtd. avg.) | $39.3M | $39.5M | $39.5M | $39.4M | $39.4M | $39.3M | $39.2M | $39.0M | $38.7M | $38.0M |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $165.1M | $164.6M | $146.4M | $164.4M | $141.4M | $161.0M | $152.5M | $140.6M | $137.9M | $115.0M |
| Receivables | $306.5M | $279.2M | $294.7M | $297.0M | $254.2M | $252.3M | $255.1M | $245.0M | $244.2M | $209.5M |
| Inventory | $343.0M | $296.8M | $292.6M | $338.3M | $280.6M | $245.0M | $185.0M | $156.6M | $153.7M | $103.1M |
| Total current assets | $869.3M | $803.0M | $786.3M | $880.1M | $792.8M | $801.4M | $693.4M | $656.6M | $622.3M | $472.8M |
| Property, plant and equipment | $283.1M | $211.9M | $211.9M | $207.6M | $207.8M | $189.6M | $167.0M | $157.9M | $157.0M | $148.7M |
| Goodwill | $731.6M | $620.9M | $627.5M | $620.6M | $636.9M | $443.3M | $436.7M | $413.6M | $422.2M | $333.3M |
| Other intangibles | $299.1M | $246.4M | $266.1M | $281.9M | $306.9M | $161.1M | $171.3M | $169.5M | $183.1M | $77.0M |
| Total assets | $2.55B | $2.21B | $2.17B | $2.38B | $2.40B | $1.92B | $1.78B | $1.61B | $1.68B | $1.35B |
| Accounts payable | $110.8M | $108.2M | $111.9M | $112.5M | $106.8M | $86.9M | $89.1M | $78.4M | $87.1M | $62.7M |
| Short-term debt | $8.2M | $26.4M | $26.5M | $7.4M | $0 | $20.0M | $20.0M | $20.0M | $26.7M | $26.7M |
| Total current liabilities | $289.2M | $288.1M | $332.8M | $345.9M | $330.6M | $310.5M | $277.5M | $282.1M | $289.3M | $221.4M |
| Long-term debt | $572.7M | $481.6M | $575.2M | $565.4M | $597.7M | $287.2M | $328.4M | $341.3M | $447.8M | $363.8M |
| Total liabilities | $1.19B | $1.06B | $1.20B | $1.45B | $1.56B | $1.07B | $1.01B | $968.5M | $1.08B | $792.7M |
| Retained earnings | $1.55B | $1.35B | $1.14B | $1.16B | $1.05B | $1.10B | $1.01B | $935.6M | $868.7M | $901.4M |
| Total equity | $1.37B | $1.14B | $966.8M | $923.7M | $834.4M | $839.2M | $725.8M | $633.9M | $597.6M | $558.2M |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $363.9M | $296.4M | $92.9M | $157.5M | $199.1M | $206.6M | $165.0M | $263.9M | $230.3M | $134.9M |
| Depreciation and amortisation | $71.6M | $64.3M | $60.8M | $56.3M | $45.4M | $39.7M | $38.0M | $37.9M | $37.9M | $35.3M |
| Stock-based compensation | $15.2M | $18.2M | $30.0M | $19.6M | $18.9M | $6.9M | $13.8M | $12.2M | $11.8M | $9.2M |
| Capital expenditure | $68.4M | $54.2M | $42.8M | $42.6M | $43.8M | $48.9M | $36.6M | $34.0M | $23.7M | $25.5M |
| Investing cash flow | -$257.6M | -$53.8M | -$40.0M | -$4.5M | -$415.5M | -$72.8M | -$64.2M | -$84.4M | -$239.2M | -$25.5M |
| Financing cash flow | -$105.5M | -$208.7M | -$52.3M | -$113.3M | $203.9M | -$126.5M | -$84.6M | -$163.3M | $25.6M | -$99.3M |
| Dividends paid | $82.3M | $78.8M | $73.5M | $71.5M | $68.6M | $66.6M | $63.5M | $57.2M | $52.5M | $49.1M |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0000066570-26-000005.
Others in SIC 3842
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| ISRG | INTUITIVE SURGICAL INC | $129.55B | 46.6x | 20.5% |
| EW | Edwards Lifesciences Corp | $51.82B | 49.1x | 11.5% |
| STE | STERIS plc | $21.90B | 28.3x | 8.7% |
| ZBH | ZIMMER BIOMET HOLDINGS, INC. | $18.71B | 27.6x | 7.2% |
| ALGN | ALIGN TECHNOLOGY INC | $11.27B | 28.1x | 0.9% |
| ESTA | ESTABLISHMENT LABS HOLDINGS INC. | $2.21B | — | 27.1% |
| CDRE | Cadre Holdings, Inc. | $1.27B | 29.2x | 7.5% |
| ENOV | Enovis CORP | $1.07B | — | 6.7% |